Anthony Rohr

COO, Genesis Drug Discovery & Development, GD3 at Genesis Biotechnology Group

Anthony joined the GBG team in 2018. As Chief Operating Officer of GD3, he provides operational leadership, oversight, and coordination across all GD3 companies. This includes but is not limited to the efficiency and harmonization of processes, metrics, and justification of capital purchases; as well as the vetting and transition of additional companies into the GD3 group of companies.

Anthony began his career with PharmOptima as Business Development Manager. In 2020, he transitioned into the role of Chief Executive Officer of PharmOptima, a position he held until transitioned into his new role.

Anthony brought over 15 years of experience in the Preclinical Research industry to the GBG Team. He previously held a position with MPI Research, Inc., as Senior Director of Operations. Anthony was also the owner of Knowledgeable and Focused Consulting, where he provided science and business development consulting services to Biotech, CRO, and Pharma.

Anthony received his BS in Biomedical Sciences from Western Michigan University in Kalamazoo, MI.

Links

Previous companies

Baylor College of Medicine logo

Timeline

  • COO, Genesis Drug Discovery & Development, GD3

    Current role

View in org chart